IEX Method Transfer: Replicating a Method for Monoclonal Antibody Analysis on an ACQUITY Arc System
Applications | 2015 | WatersInstrumentation
Monoclonal antibody charge variant analysis by ion exchange chromatography is critical for ensuring consistent quality and safety of protein-based biopharmaceuticals. Monitoring acidic and basic variants of therapeutic antibodies such as rituximab supports tight process control throughout fermentation, purification, and formulation stages.
The primary goal was to demonstrate seamless transfer of an established cation exchange method for rituximab from an Agilent 1100 Series HPLC System to the Waters ACQUITY Arc System using Arc Multi-flow path technology. Key objectives included comparing chromatographic selectivity, resolution, retention times, and quantitative variant profiles without adjusting original method parameters.
A USP-based ion exchange protocol employed a Dionex ProPac WCX-10 column operated at 30 °C with a gradient from 0.02 M MES buffer to 0.02 M MES plus 0.4 M sodium chloride at pH 6.0. Detection was performed at 280 nm with a 20 Hz sampling rate. The legacy setup used an Agilent 1100 Series HPLC with quaternary pump and DAD detector. The target platform was the ACQUITY Arc System configured with a quaternary pump, 2489 UV/Visible detector, and Empower 3 chromatography data software.
Chromatograms on both platforms showed virtually identical selectivity and resolution for six charge variants and the main peak. Relative retention time differences were under 0.006 across all species. Resolution between the main peak and lysine variant averaged 1.95 on the Agilent system and 2.09 on the Arc System, both exceeding the USP requirement of 1.5. Reproducibility tests of five injections on the ACQUITY Arc System yielded retention time RSDs below 0.5% and peak area RSDs under 1.2% for variant groups. Quantitative comparison indicated main peak areas around 70%, acidic variants about 19.8%, and basic variants near 10%, with inter-system differences within 1%.
The adoption of advanced UHPLC columns and high-sensitivity detectors will enhance resolution and throughput. Automated multi-path workflows and cloud-based data management will improve method robustness and compliance. Novel ion exchange stationary phases may expand selectivity for emerging biotherapeutics and biosimilars.
The ACQUITY Arc System successfully replicated a legacy cation exchange method for rituximab analysis, achieving comparable retention, resolution, and quantitation of charge variants. High reproducibility and straightforward method transfer underscore its value for consistent quality monitoring throughout biopharmaceutical development and manufacturing.
1. USP Medicines Compendium standard method for rituximab IEX analysis.
HPLC
IndustriesPharma & Biopharma
ManufacturerWaters
Summary
Significance of the Topic
Monoclonal antibody charge variant analysis by ion exchange chromatography is critical for ensuring consistent quality and safety of protein-based biopharmaceuticals. Monitoring acidic and basic variants of therapeutic antibodies such as rituximab supports tight process control throughout fermentation, purification, and formulation stages.
Objectives and Study Overview
The primary goal was to demonstrate seamless transfer of an established cation exchange method for rituximab from an Agilent 1100 Series HPLC System to the Waters ACQUITY Arc System using Arc Multi-flow path technology. Key objectives included comparing chromatographic selectivity, resolution, retention times, and quantitative variant profiles without adjusting original method parameters.
Methodology and Instrumentation
A USP-based ion exchange protocol employed a Dionex ProPac WCX-10 column operated at 30 °C with a gradient from 0.02 M MES buffer to 0.02 M MES plus 0.4 M sodium chloride at pH 6.0. Detection was performed at 280 nm with a 20 Hz sampling rate. The legacy setup used an Agilent 1100 Series HPLC with quaternary pump and DAD detector. The target platform was the ACQUITY Arc System configured with a quaternary pump, 2489 UV/Visible detector, and Empower 3 chromatography data software.
Results and Discussion
Chromatograms on both platforms showed virtually identical selectivity and resolution for six charge variants and the main peak. Relative retention time differences were under 0.006 across all species. Resolution between the main peak and lysine variant averaged 1.95 on the Agilent system and 2.09 on the Arc System, both exceeding the USP requirement of 1.5. Reproducibility tests of five injections on the ACQUITY Arc System yielded retention time RSDs below 0.5% and peak area RSDs under 1.2% for variant groups. Quantitative comparison indicated main peak areas around 70%, acidic variants about 19.8%, and basic variants near 10%, with inter-system differences within 1%.
Benefits and Practical Applications of the Method
- Enables direct replication of legacy HPLC methods or upgrade to UHPLC separations without parameter changes
- Delivers consistent charge variant profiles for regulatory-compliant quality control in biopharmaceutical production
- Arc Multi-flow path technology streamlines method transfer and supports both routine testing and high throughput workflows
Future Trends and Potential Applications
The adoption of advanced UHPLC columns and high-sensitivity detectors will enhance resolution and throughput. Automated multi-path workflows and cloud-based data management will improve method robustness and compliance. Novel ion exchange stationary phases may expand selectivity for emerging biotherapeutics and biosimilars.
Conclusion
The ACQUITY Arc System successfully replicated a legacy cation exchange method for rituximab analysis, achieving comparable retention, resolution, and quantitation of charge variants. High reproducibility and straightforward method transfer underscore its value for consistent quality monitoring throughout biopharmaceutical development and manufacturing.
Reference
1. USP Medicines Compendium standard method for rituximab IEX analysis.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Transfer of an SEC Method for Monoclonal Antibody Analysis from HPLC to UHPLC Using the ACQUITY Arc System
2015|Waters|Applications
Transfer of an SEC Method for Monoclonal Antibody Analysis from HPLC to UHPLC Using the ACQUITY Arc System Brooke M. Koshel and Sean M. McCarthy Waters Corporation, Milford, MA, USA A P P L I C AT I O N…
Key words
arc, arcacquity, acquitysec, secuhplc, uhplcmonomer, monomerhplc, hplcdimer, dimersystem, systemhmw, hmwplc, plcpeak, peakequivalency, equivalencyretention, retentionmethod, methodmonoclonal
Method Transfer of a Monoclonal Antibody Ion-Exchange Separation Across Biocompatible Systems
2018|Waters|Applications
[ APPLICATION NOTE ] Method Transfer of a Monoclonal Antibody Ion-Exchange Separation Across Biocompatible Systems Paula Hong, Zhimin Li, and Patricia R. McConville Waters Corporation, Milford, MA, USA APPLICATION BENEFITS ■■ ■■ INTRODUCTION Biocompatible system for ion exchange To evaluate…
Key words
bio, bioarc, arciggkk, iggkkacquity, acquitybiocompatible, biocompatiblevariants, variantsigg, iggmonoclonal, monoclonalantibody, antibodyacidic, acidicsystem, systemquaternary, quaternaryexchange, exchangesystems, systemsiggk
Method Transfer and Reliability of the ACQUITY Arc for Peptide Mapping
2016|Waters|Applications
Method Transfer and Reliability of the ACQUITY Arc for Peptide Mapping Brooke M. Koshel and Sean M. McCarthy Waters Corporation, Milford, MA, USA A P P L I C AT I O N B E N E F I T…
Key words
arc, arcacquity, acquitypeptide, peptideretention, retentionmapping, mappingreliability, reliabilityrrt, rrtmethod, methodsystem, systemqda, qdatime, timemap, maptransfer, transferuhplc, uhplcmin
METHOD TRANSFER AND ROUTINE ANALYSIS OF PROTEIN AND PEPTIDE-BASED DRUG PRODUCTS USING A BIOCOMPATIBLE UHPLC SYSTEM
2019|Waters|Posters
METHOD TRANSFER AND ROUTINE ANALYSIS OF PROTEIN AND PEPTIDE-BASED DRUG PRODUCTS USING A BIOCOMPATIBLE UHPLC SYSTEM Brooke M. Koshel, Robert Birdsall, Corey Reed, Stephan Koza, Zhimin Li, Paula Hong, Joe Fredette, and Scott Berger Waters Corporation INTRODUCTION Many of the…
Key words
bio, bioarc, arcsystem, systemmodernization, modernizationmean, meanacquity, acquitylegacy, legacyigg, iggtransfer, transferhplc, hplcrsd, rsduhplc, uhplcdevelopment, developmentequivalency, equivalencyclass
